Literature DB >> 18424475

Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation.

Nikolaos A Patsopoulos1, Evangelos Evangelou, John P A Ioannidis.   

Abstract

BACKGROUND: Several approaches are available for evaluating heterogeneity in meta-analysis. Sensitivity analyses are often used, but these are often implemented in various non-standardized ways.
METHODS: We developed and implemented sequential and combinatorial algorithms that evaluate the change in between-study heterogeneity as one or more studies are excluded from the calculations. The algorithms exclude studies aiming to achieve either the maximum or the minimum final I(2) below a desired pre-set threshold. We applied these algorithms in databases of meta-analyses of binary outcome and >/=4 studies from Cochrane Database of Systematic Reviews (Issue 4, 2005, n = 1011) and meta-analyses of genetic associations (n = 50). Two I(2) thresholds were used (50% and 25%).
RESULTS: Both algorithms have succeeded in achieving the pre-specified final I(2) thresholds. Differences in the number of excluded studies varied from 0% to 6% depending on the database and the heterogeneity threshold, while it was common to exclude different specific studies. Among meta-analyses with initial I(2) > 50%, in the large majority [19 (90.5%) and 208 (85.9%) in genetic and Cochrane meta-analyses, respectively] exclusion of one or two studies sufficed to decrease I(2) < 50%. Similarly, among meta-analyses with initial I(2) > 25%, in most cases [16 (57.1%) and 382 (81.3%), respectively) exclusion of one or two studies sufficed to decrease heterogeneity even <25%. The number of excluded studies correlated modestly with initial estimated I(2) (correlation coefficients 0.52-0.68 depending on algorithm used).
CONCLUSIONS: The proposed algorithms can be routinely applied in meta-analyses as standardized sensitivity analyses for heterogeneity. Caution is needed evaluating post hoc which specific studies are responsible for the heterogeneity.

Mesh:

Year:  2008        PMID: 18424475      PMCID: PMC6281381          DOI: 10.1093/ije/dyn065

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  25 in total

1.  Methods for exploring heterogeneity in meta-analysis.

Authors:  F Song; T A Sheldon; A J Sutton; K R Abrams; D R Jones
Journal:  Eval Health Prof       Date:  2001-06       Impact factor: 2.651

Review 2.  Approaches to heterogeneity in meta-analysis.

Authors:  D B Petitti
Journal:  Stat Med       Date:  2001-12-15       Impact factor: 2.373

3.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

4.  Controlling the risk of spurious findings from meta-regression.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2004-06-15       Impact factor: 2.373

Review 5.  Uncertainty in heterogeneity estimates in meta-analyses.

Authors:  John P A Ioannidis; Nikolaos A Patsopoulos; Evangelos Evangelou
Journal:  BMJ       Date:  2007-11-03

6.  Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head.

Authors:  Jesse A Berlin; Jill Santanna; Christopher H Schmid; Lynda A Szczech; Harold I Feldman
Journal:  Stat Med       Date:  2002-02-15       Impact factor: 2.373

7.  Detecting and describing heterogeneity in meta-analysis.

Authors:  R J Hardy; S G Thompson
Journal:  Stat Med       Date:  1998-04-30       Impact factor: 2.373

Review 8.  Why sources of heterogeneity in meta-analysis should be investigated.

Authors:  S G Thompson
Journal:  BMJ       Date:  1994-11-19

Review 9.  Somatostatin analogues for acute bleeding oesophageal varices.

Authors:  P C Gøtzsche; A Hróbjartsson
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

10.  Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.

Authors:  Christopher H Schmid; Paul C Stark; Jesse A Berlin; Paul Landais; Joseph Lau
Journal:  J Clin Epidemiol       Date:  2004-07       Impact factor: 6.437

View more
  274 in total

1.  Association of C47T polymorphism in SOD2 gene with coronary artery disease: a case-control study and a meta-analysis.

Authors:  Changwei Tian; Tongtao Liu; Shengxia Fang; Xunbo Du; Chongqi Jia
Journal:  Mol Biol Rep       Date:  2011-12-15       Impact factor: 2.316

2.  Physical therapy management of ventilated patients with acute respiratory distress syndrome or severe acute lung injury.

Authors:  Frank Chung; Dan Mueller
Journal:  Physiother Can       Date:  2011-04-13       Impact factor: 1.037

Review 3.  Periconceptional folic acid fortification for the risk of gestational hypertension and pre-eclampsia: a meta-analysis of prospective studies.

Authors:  Xiaorong Yang; Hui Chen; Yihui Du; Shuting Wang; Zhiping Wang
Journal:  Matern Child Nutr       Date:  2015-08-11       Impact factor: 3.092

Review 4.  Coffee consumption and the risk of cutaneous melanoma: a meta-analysis.

Authors:  Jia Wang; Xutong Li; Dongfeng Zhang
Journal:  Eur J Nutr       Date:  2015-12-22       Impact factor: 5.614

5.  Depression and telomere length: A meta-analysis.

Authors:  Kathryn K Ridout; Samuel J Ridout; Lawrence H Price; Srijan Sen; Audrey R Tyrka
Journal:  J Affect Disord       Date:  2015-12-02       Impact factor: 4.839

6.  Association of the C47T polymorphism in SOD2 with diabetes mellitus and diabetic microvascular complications: a meta-analysis.

Authors:  C Tian; S Fang; X Du; C Jia
Journal:  Diabetologia       Date:  2010-12-22       Impact factor: 10.122

7.  A Systematic Review and Meta-Analysis of the Risk of Disruptive Behavioral Disorders in the Offspring of Parents with Severe Psychiatric Disorders.

Authors:  Getinet Ayano; Kim Betts; Joemer Calderon Maravilla; Rosa Alati
Journal:  Child Psychiatry Hum Dev       Date:  2021-02

8.  Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.

Authors:  Aaron P Thrift; Lesley A Anderson; Liam J Murray; Michael B Cook; Nicholas J Shaheen; Joel H Rubenstein; Hashem B El-Serag; Thomas L Vaughan; Jennifer L Schneider; David C Whiteman; Douglas A Corley
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

9.  Hypertonic saline or mannitol for treating elevated intracranial pressure in traumatic brain injury: a meta-analysis of randomized controlled trials.

Authors:  Jiajie Gu; Haoping Huang; Yuejun Huang; Haitao Sun; Hongwu Xu
Journal:  Neurosurg Rev       Date:  2018-06-15       Impact factor: 3.042

Review 10.  Association of ADHD medications with the risk of cardiovascular diseases: a meta-analysis.

Authors:  Hui Liu; Wenjing Feng; Dongfeng Zhang
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-08-24       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.